We are Dedicated to
Biopharmaceutical
Research & Advancement

What We Do
Generex Biotechnology Corp., is a biopharmaceutical company that is actively involved in discovery, research, development, and financing of new compounds, therapies, diagnostics, delivery systems, and medical technologies.
News
  1. Generex Announces Results of Annual Stockholders’ Meeting
    November 27, 2017
    November 27, 2017 09:00 AM Eastern Standard Time MIRAMAR, Fla.--(BUSINESS WIRE)--Generex Biotechnology Corporation (OTCPink:GNBT) (www.generex.com) today announced the results of the annual meeting of the Company’s stockholders held on November 21, 2017.
    READ MORE
  2. Generex Announces Collaboration with Shenzhen BioScien Pharmaceuticals to Develop and Commercialize the AE37 Immunotherapeutic Vaccine for the Treatment of Prostate Cancer in China
    December 7, 2017
    MIRAMAR, Florida, December 7, 2017 (BUSINESS WIRE) – Generex Biotechnology Corporation (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) (www.generex.com) today announced that its wholly-owned subsidiary, Antigen Express, Inc. (www.antigenexpress.com), has entered into a License and Research Agreement with Shenzhen BioScien Pharmaceuticals Co. Ltd. www.BioScien.cn to develop and commercialize the Antigen Express AE37 immunotherapeutic vaccine for prostate cancer in the People’s Republic of China (including Taiwan, Hong Kong, and Macau).
    READ MORE
  3. Generex Announces Upgrade to OTCQB® Venture Market
    November 30, 2017
    November 30, 2017 - MIRAMAR, Fla. Generex Biotechnology Corporation (GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) (www.generex.com) today announced that trading in its common stock will be upgraded to the OTCQB® Venture Market on November 30, 2017 after a successful application to up-list from the OTC Pink Market.
    READ MORE
  4. Generex Announces Exclusive Distribution Contract For Rapid 1-2-3® Hema HIV EXPRESS® in Chile
    October 12, 2017
    MIRAMAR, Fla.--(BUSINESS WIRE)--Generex Biotechnology Corporation (OTCPink:GNBT) (www.generex.com) today announced that its subsidiary, Hema Diagnostic Systems, LLC (www.hemadiagnosticsystems.com), has entered into an exclusive contract with Imerlab Sociedad Comercial Limitada (www.imerlab.cl) for the distribution and sale of the Rapid 1-2-3® Hema HIV EXPRESS® diagnostic test in the Republic of Chile.
    READ MORE